---
title: "$Tempus AI(TEM.US)The core problem Tempus AI solves can be summarized as: breaking down the "inf"
description: "$Tempus AI(TEM.US)The core problem Tempus AI solves can be summarized as: breaking down the "information silos" within the healthcare system through structured data, eliminating blindness in t"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/38787434.md"
published_at: "2026-02-19T15:12:48.000Z"
author: "[自嘲熊](https://longbridge.com/en/profiles/11984584)"
---

# $Tempus AI(TEM.US)The core problem Tempus AI solves can be summarized as: breaking down the "inf

$Tempus AI(TEM.US)The core problem Tempus AI solves can be summarized as: breaking down the "information silos" within the healthcare system through structured data, eliminating blindness in the treatment process.

In traditional healthcare, doctors' medical records (clinical data) and laboratory genetic testing (molecular data) are often disconnected, leading to many decisions relying on experience rather than complete evidence. Tempus addresses the following pain points for different groups in the healthcare chain:

1\. Clinical Decision-Making: From "Based on Experience" to "Based on Evidence"

• Integrating Siloed Data: Deeply connecting fragmented \*\*genetic data (molecular) with electronic medical records (clinical)\*\*, allowing doctors to reference the real-world efficacy of "patients with similar genetic characteristics" in real-time during diagnosis.

• Bridging Care Gaps: AI automatically monitors medical records, proactively alerting doctors to targeted drugs or clinical trial opportunities they haven't yet discovered, preventing missed optimal treatment windows.

2\. Patient Treatment: From "One-Size-Fits-All" to "Precision"

• Farewell to Trial-and-Error Therapy: Precisely matching drugs based on genetic mutations, reducing ineffective chemotherapy.

• Technological Breakthrough: Using RNA testing (e.g., HRD-RNA) to identify hidden tumor characteristics that traditional DNA testing cannot detect, finding hope for survival for patients with difficult-to-treat diseases like pancreatic cancer.

3\. Drug Development: From "High Time-Consuming" to "High Efficiency"

• Shortening R&D Cycles: Pharmaceutical companies use the LENS platform (generative AI) to instantly search vast amounts of real-world data, quickly screening eligible trial participants.

• Improving Trial Success Rates: Using real data to precisely design enrollment criteria, significantly reducing the risk of clinical trial failure.

4\. System Value: From "Useless Information" to "Structured Assets"

• Data Assetization: Using AI to transform 80% of chaotic unstructured data (such as images, notes) into structured models, reducing trillions in resource waste caused by information inefficiency within the healthcare system.

In a nutshell: Tempus transforms static medical reports into a dynamic intelligent system, evolving treatment from "based on average probability" to "based on individual data."

### Related Stocks

- [TEM.US - Tempus AI](https://longbridge.com/en/quote/TEM.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.